---
title: "Daiichi Sankyo Company: Q1 FY 2026 revenue up 21% YoY, forecast raised on strong oncology sales and yen weakness"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294542919.md"
description: "Revenue surged 21% YoY in Q1 FY 2026, driven by ENHERTU and DATROWAY, but operating profit fell due to restructuring costs. FY 2026 revenue and profit forecasts were raised, with strong U.S. sales and yen depreciation as key drivers.Based on DisclaimerThis is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source."
datetime: "2026-07-31T17:35:18.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294542919.md)
  - [en](https://longbridge.com/en/news/294542919.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294542919.md)
generator: "portal-rs"
---

# Daiichi Sankyo Company: Q1 FY 2026 revenue up 21% YoY, forecast raised on strong oncology sales and yen weakness

Revenue surged 21% YoY in Q1 FY 2026, driven by ENHERTU and DATROWAY, but operating profit fell due to restructuring costs. FY 2026 revenue and profit forecasts were raised, with strong U.S. sales and yen depreciation as key drivers.

Based on 

**Disclaimer**

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

### Related Stocks

- [DSNKY.US](https://longbridge.com/en/quote/DSNKY.US.md)
- [4568.JP](https://longbridge.com/en/quote/4568.JP.md)

## Related News & Research

- [Coincheck Group N.V. GAAP EPS of ¥6.92, revenue of ¥114.33B](https://longbridge.com/en/news/296104610.md)
- [AI isn’t close to curing cancer. This startup says it knows what it will take.](https://longbridge.com/en/news/296352961.md)
- [Ascentage Pharma posts interim results presentation on 1H 2026 business update](https://longbridge.com/en/news/296418315.md)
- [TriSalus Highlights Tumor-Treatment Expansion, FDA Catalyst at Growth Conference](https://longbridge.com/en/news/296174254.md)
- [One Platform, Every Ailment: Hinge Health's Gamble](https://longbridge.com/en/news/296483875.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**